Journal List > Korean J Neurotrauma > v.11(1) > 1058758

Kim, Cheong, Ryu, Kim, and Kim: Bone Flap Resorption Following Cranioplasty after Decompressive Craniectomy: Preliminary Report

Abstract

Objective

Resorption of autologous bone flap grafts is a known long-term complication of cranioplasty following decompressive craniectomy (DC). We analyzed our data to identify risk factors for bone flap resorption (BFR) following cranioplasty.

Methods

A total of 162 patients who underwent cranioplasty following DC due to life-threatening elevated intracranial pressure between October 2003 and December 2012, were included in our investigation. Follow-up exceeded one year.

Results

BFR occurred as a long-term complication in 9 of the 162 patients (5.6%). The affected patients consisted of individuals who had undergone DC for traumatic brain injury (TBI; n=4), for subarachnoid hemorrhage (SAH; n=3), for cerebral infarction (n=1), and intracerebral hemorrhage (n=1). Logistic regression analysis identified no significant risk factors for BFR.

Conclusion

TBI and SAH as initial diagnoses are more often associated with BFR than other diagnoses. This finding may influence future surgical decision making, especially in patients with possible risk factors for BFR. A prospective study with a large number of patients is needed to identify potential predictors of BFR such as bone flap sterilization and preservation.

Introduction

Decompressive craniectomy (DC) is performed in medically refractory situations involving elevated intracranial pressure (ICP), such as intracerebral bleeding, traumatic brain injury (TBI), and ischemic brain lesion leading to severe brain swelling.517) Cranioplasty is then performed for cosmetic, protective and physiologic reasons after the cerebral edema has resolved.467) Cranioplasty itself is known to have a higher postoperative complication rate than other elective cranial procedures, such as wound infection or dehiscence, intracranial hematoma, and sunken bone flap and seizure.2922) Bone flap resorption (BFR), one of the long-term complications of cranioplasty, can result in structural breakdown.121421) Because BFR requires reoperation and replacement of the flap with plastic, metal, or other materials, investigation of the frequency of BFR and the associated risk factors is needed. The purposes of this study were to carry out such an investigation, along with a review of the literature, and to suggest optimal strategies for improving prognosis of patients who require cranioplasty.

Materials and Methods

Definition of BFR

Cosmetic disfigurement was the main complaint in patients diagnosed with BFR. We defined BFR as complete or partial resorption of the bone flap covering a lesion of diameter >1 cm, where the remnant thickness of the bone flap was less than 50% of that of the contralateral region of the skull (Figure 1).

Patients

From October 2003 to December 2012, 162 patients underwent cranioplasty after DC in our institution, and were followed up for at least a year. The DC was performed for intractably elevated ICP occurring despite medical treatment in an acute situation, or during the course of intensive care. We performed a retrospective chart review examining demographic data, diagnosis, time interval between DC and cranioplasty, and number of major cranial operations before cranioplasty. Major cranial operations were defined as operations that needed craniotomy in which a bone flap was taken. We included patients where the cranioplasty was performed to repair skull defects after DC, and excluded patients where it was performed for other reasons such as reconstruction of a depressed skull fracture. Initial diagnoses were classified in 5 categories; 1) TBI, 2) cerebral infarction, 3) subarachnoid hemorrhage (SAH), 4) intracerebral hemorrhage (ICH), and 5) others.

Bone flap preservation

Connective tissue such as pericranium, muscle, fascia, and galea on the bone flap was removed after the bone flap was obtained. Then the cleaned bone flap was dried in an Amsco® Warming Cabinet (STERIS Corporation, Mentor, OH, USA) at 110-120℃ for 1-2 days. After drying it was sterilized at 70℃ for 75 minutes with a Sterrad® NX™ Sterilization System (Advanced Sterilization Products, Irvine, CA, USA) that exploits hydrogen peroxide and low temperature gas plasma. After sterilization, the flap was kept aseptically at room temperature, and resterilized twice more in the same manner, one and two days before the planned cranioplasty.

Operative procedure

The subsequent cranioplasty was scheduled by the surgeon after resolution of the brain edema, taking into account the patient's neurological status, of course, and also various other factors including the patient's general medical condition and economic status.
Under general anesthesia, the cutis and subcutis were opened along the previous incisions and dissected from the cranium and the temporal muscle. After trephination of multiple holes for epidural tack-up suturing in the flap, it was fixed in its original position, contacting the edge of the bone defect as closely as possible with titanium plates and screws. The temporal muscle, if preserved, was separated from the dura mater and fixed onto the bone flap. Epidural and subcutaneous drains were inserted before wound closure, and antibiotics were administered intravenously for 7 days after the cranioplasty.

Statistical analysis

We performed a logistic-regression analysis to identify risk factor for BFR. To solve the problem of multicollinearity due to closely correlated variables, we calculated variance inflation factors (VIFs) and excluded variables with VIFs >10. Thereafter variables were selected by backward elimination.

Results

Patient characteristics

Of the 162 patients who underwent cranioplasty, 110 were male and 52 female. Patient age ranged from 13 to 85 years (mean, 49.99 years), and the time interval between DC and cranioplasty varied from 29 days to 10 years (mean, 5.48 months). We categorized 129 patients according to the number of major cranial operation undergone before cranioplasty: 81 had no major cranial operation before cranioplasty, 28 had 1 operation, 13 had 2 operations, 3 had 3 operations, another 3 patients had 4 operations, and 1 patient had 5 operations. The other 33 patients from whose medical records this information had been omitted were excluded.
We also categorized the patients by their initial diagnosis: 56 cranioplasties were performed in patients with TBI, 15 in patients with cerebral infarction, 30 in patients with SAH, 15 in patients with ICH, and 13 in patients with other diagnoses. BFR occurred in 4 patients with TBI, 1 with cerebral infarction, 3 with SAH, and 1 patient with some other diagnosis. Patient characteristics at initial diagnosis are shown in (Table 1).

Risk factors for BFR

No variable was significantly associated with BFR in the logistic-regression analysis. This may have been primarily due to the small BFR sample size. However, there was a relative risk according to initial diagnosis: cerebral infarction [odds ratio (OR) 5.04], TBI (OR 4.08), and SAH (OR 3.93). Table 2 presents the results of the logistic-regression analysis.

Discussion

DC is the standard surgical option for malignant cerebral edema resulting from intracranial hemorrhage, cerebral infarction and TBI.517) After the cerebral swelling has resolved, cranioplasty is then performed to correct the skull defect. This is not just a cosmetic measure, since it also provides important support, and restores normal cerebrospinal fluid flow, reducing the formation of pseudomeningoceles and protecting vital structures.67) Because almost all patients surviving a DC require cranioplasty, the complications of this second operation need to be acknowledged. Cranioplasty always carries the risk of complications, especially as the patients are often weakened by the impact of the first event that required DC. BFR is one of the known long-term complications of cranioplasty following DC. It has been reported in 7.2-50% of cases.91011141621)
Survival of a bone implant is acknowledged to depend on the reaction of the surrounding tissue and on functional contact between the cancellous bone and adjacent resident bone.20) According to Kalfas,15) it is crucial that inflammation and revascularization occur in the first 1 to 2 weeks for bone graft healing. The incorporation and remodeling of a bone graft require that mesenchymal cells have vascular access to the graft in order to differentiate into osteoblasts and osteoclasts.15) Osteoinduction refers to the process by which primitive mesenchymal cells differentiate into osteoprogenitor cells. These latter then differentiate into osteoblasts that can form new bone to replace the necrotic bone, which is gradually absorbed. Osteoprogenitor cells from the surrounding tissue migrate into the three-dimensional structure of bony and protein matrix in a process called osteoconduction. It is now understood that auto- and allo-grafts rely on osteoconduction as the main mechanism underlying cranioplasty.20) As healing progresses, the bone graft is remodeled through resorption of necrotic bone and formation of new bone. We believe that BFR may occur due to dysregulation of osteoconduction.
We failed to identify any variable significantly associated with BFR. However, there was a relative risk with TBI and cerebral infarction as initial diagnosis. The risk of BFR was 5-fold greater in patients with cerebral infarction than in those without cerebral infarction, and 4-fold greater in those with TBI than in those without TBI. There has been no study, to our knowledge, of the relationship between cerebral infarction and BFR. We suggest that atherosclerotic changes due to poor microcirculation in ischemic stroke patients may inhibit revascularization in the bone healing process. On the other hand there are some studies concerned with the relationship between BFR and TBI. According to Schuss et al.,21) BFR occurs significantly more often in patients who undergo DC for TBI than in those undergoing DC because of any other primary diagnosis (8.5% vs. 1.8%). They also found that BFR was more frequent in patients with multiple fractures or fragments in the reinserted bone flap than in those without such multiple fractures or fragments (17.2% vs. 2.2%).21) We suppose that the larger surface area of bony fragments accompanying multiple fractures make bone proteins more susceptible to denaturation during the sterilization process, thus impairing osteogenesis. Moreover comminuted fractures are known to heal less well because close approximation of the bone fragment is often difficult. There are recent reports that large bone flaps have a higher resorption rate.1016) Piedra et al.19) found that freezer times greater than 6 weeks led to a 3-fold increase in BFR (42% vs. 14%). Also, younger age has been identified as a risk factor for BFR by some authors.81621)
The high infection and BFR rates following cranioplasty raise important questions regarding the optimal sterilization and preservation methods. However, there are currently no standardized guidelines for sterilization and preservation of skull bone flaps for cranioplasty. Im et al.13) compared two sterilization methods, and found no significant difference in bone resorption rates between ethylene oxide gas sterilization and chemical sterilization. Several authors have investigated methods for preserving bone flaps for cranioplasty. These methods can be divided into two categories; those that retain the bone flap in the patient's body and those that store the flap extracorporeally.13141822) For extracorporeal preservation, cryopreservation has become the most widely used technique. However, complication rates appear to vary with the freezing temperatures, and we ourselves maintained flaps in room air in our series. Hence, further clinical studies will be needed to establish the best method of bone flap preservation.
Our study has several limitations. First, the number of complications was too small to identify significant risk factors. Nevertheless analyzing the risk factors for BFR is important because it can help to judge the prognosis of patients who are planned to undergo cranioplasty. Therefore further clinical studies with a much larger affected population are needed. Also ours was a retrospective study from a single institution, not a prospective trial, and there was no control group to establish the relationship between bone flap preservation and BFR.

Conclusion

DC has become an inherent part of the treatment of life-threatening ICP, but many questions regarding cranioplasty remain unanswered. We have shown that cerebral infarction and TBI are possible risk factors for BFR after cranioplasty. To more definitively elucidate which factors affect BFR, a prospective controlled study with a large number of patients is needed.

Notes

The authors have no financial conflicts of interest.

References

1. Bhaskar IP, Zaw NN, Zheng M, Lee GY. Bone flap storage following craniectomy: a survey of practices in major Australian neurosurgical centres. ANZ J Surg. 2011; 81:137–141. PMID: 21342384.
crossref
2. Bobinski L, Koskinen LO, Lindvall P. Complications following cranioplasty using autologous bone or polymethylmethacrylate-retrospective experience from a single center. Clin Neurol Neurosurg. 2013; 115:1788–1791. PMID: 23725651.
crossref
3. Bruce JN, Bruce SS. Preservation of bone flaps in patients with postcraniotomy infections. J Neurosurg. 2003; 98:1203–1207. PMID: 12816265.
crossref
4. Chang V, Hartzfeld P, Langlois M, Mahmood A, Seyfried D. Outcomes of cranial repair after craniectomy. J Neurosurg. 2010; 112:1120–1124. PMID: 19612971.
crossref
5. Diedler J, Sykora M, Blatow M, Jüttler E, Unterberg A, Hacke W. Decompressive surgery for severe brain edema. J Intensive Care Med. 2009; 24:168–178. PMID: 19321537.
crossref
6. Dujovny M, Aviles A, Agner C, Fernandez P, Charbel FT. Cranioplasty: cosmetic or therapeutic? Surg Neurol. 1997; 47:238–241. PMID: 9068693.
crossref
7. Dujovny M, Fernandez P, Alperin N, Betz W, Misra M, Mafee M. Post-cranioplasty cerebrospinal fluid hydrodynamic changes: magnetic resonance imaging quantitative analysis. Neurol Res. 1997; 19:311–316. PMID: 9192385.
crossref
8. Dünisch P, Walter J, Sakr Y, Kalff R, Waschke A, Ewald C. Risk factors of aseptic bone resorption: a study after autologous bone flap reinsertion due to decompressive craniotomy. J Neurosurg. 2013; 118:1141–1147. PMID: 23451904.
crossref
9. Gooch MR, Gin GE, Kenning TJ, German JW. Complications of cranioplasty following decompressive craniectomy: analysis of 62 cases. Neurosurg Focus. 2009; 26:E9. PMID: 19485722.
crossref
10. Grant GA, Jolley M, Ellenbogen RG, Roberts TS, Gruss JR, Loeser JD. Failure of autologous bone-assisted cranioplasty following decompressive craniectomy in children and adolescents. J Neurosurg. 2004; 100(2 Suppl Pediatrics):163–168. PMID: 14758944.
crossref
11. Honeybul S. Complications of decompressive craniectomy for head injury. J Clin Neurosci. 2010; 17:430–435. PMID: 20181482.
crossref
12. Honeybul S, Morrison DA, Ho K, Wiggins A, Janzen C, Kruger K. Complications and consent following decompressive craniectomy: an illustrative case study. Brain Inj. 2013; 27:1732–1736. PMID: 24087881.
crossref
13. Im SH, Jang DK, Han YM, Kim JT, Chung DS, Park YS. Long-term incidence and predicting factors of cranioplasty infection after decompressive craniectomy. J Korean Neurosurg Soc. 2012; 52:396–403. PMID: 23133731.
crossref
14. Iwama T, Yamada J, Imai S, Shinoda J, Funakoshi T, Sakai N. The use of frozen autogenous bone flaps in delayed cranioplasty revisited. Neurosurgery. 2003; 52:591–596. discussion 595-596. PMID: 12590683.
crossref
15. Kalfas IH. Principles of bone healing. Neurosurg Focus. 2001; 10:E1. PMID: 16732625.
crossref
16. Lee SH, Yoo CJ, Lee U, Park CW, Lee SG, Kim WK. Resorption of autogenous bone graft in cranioplasty: resorption and reintegration failure. Korean J Neurotrauma. 2014; 10:10–14.
crossref
17. Meyer MJ, Megyesi J, Meythaler J, Murie-Fernandez M, Aubut JA, Foley N, et al. Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions. Brain Inj. 2010; 24:706–721. PMID: 20376996.
crossref
18. Movassaghi K, Ver Halen J, Ganchi P, Amin-Hanjani S, Mesa J, Yaremchuk MJ. Cranioplasty with subcutaneously preserved autologous bone grafts. Plast Reconstr Surg. 2006; 117:202–206. PMID: 16404268.
crossref
19. Piedra MP, Ragel BT, Dogan A, Coppa ND, Delashaw JB. Timing of cranioplasty after decompressive craniectomy for ischemic or hemorrhagic stroke. J Neurosurg. 2013; 118:109–114. PMID: 23140156.
crossref
20. Redfern RM, Pülhorn H. Cranioplasty. Adv Clin Neurosci Rehabil. 2007; 7:32–34.
21. Schuss P, Vatter H, Oszvald A, Marquardt G, Imöhl L, Seifert V, et al. Bone flap resorption: risk factors for the development of a long-term complication following cranioplasty after decompressive craniectomy. J Neurotrauma. 2013; 30:91–95. PMID: 22970998.
crossref
22. Sundseth J, Sundseth A, Berg-Johnsen J, Sorteberg W, Lindegaard KF. Cranioplasty with autologous cryopreserved bone after decompressive craniectomy. Complications and risk factors for developing surgical site infection. Acta Neurochir (Wien). 2014; 156:805–811. discussion 811. PMID: 24493001.
crossref
FIGURE 1

A: Computed tomographic image of bone flap resorption demonstrating partial resorption of the bone flap, where the remnant bone flap was less than 50% as thick as the contralateral region of the skull. B: Photograph showing bone flap resorption. The multiple holes in the bone flap are thought to have been made for epidural tack-up suturing in the preceding cranioplasty. Such holes may expand as bone resorption progresses, causing cosmetic problems.

kjn-11-1-g001
TABLE 1

Characteristics of 162 patients who underwent cranioplasty

kjn-11-1-i001

TBI: traumatic brain injury, SAH: subarachnoid hemorrhage, ICH: intracerebral hemorrhage, DC: decompressive craniectomy, HTN: hypertension, DM: diabetes mellitus, BFR: bone flap resorption

TABLE 2

Logistic-regression analysis of risk factors for bone flap resorption

kjn-11-1-i002

OR: odds ratio, TBI: traumatic brain injury, SAH: subarachnoid hemorrhage, ICH: intracerebral hemorrhage, DC: decompressive craniectomy, HTN: hypertension, DM: diabetes mellitus

TOOLS
Similar articles